SCHEMBL29566622

SCHEMBL29566622

Cc1ccccc1-c1cc(Cl)nc(NS(=O)(=O)c2cnn(C)c2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HTR1A P08908 2/20 0.39
▸ HTR7 P34969 2/20 0.39
▸ TSHR P16473 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ RXFP1 Q9HBX9 1/20 0.39
▸ PIK3CD O00329 1/20 0.38
▸ PIK3CB P42338 1/20 0.38
▸ MTOR P42345 1/20 0.38
▸ PIK3CG P48736 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ SDHB P21912 1/20 0.36
▸ EGFR P00533 3/20 0.36
▸ FGFR1 P11362 3/20 0.36
▸ KDR P35968 3/20 0.36
▸ PTPN11 Q06124 1/20 0.36
▸ MALT1 Q9UDY8 1/20 0.35
▸ MAP4K1 Q92918 2/20 0.35
▸ CCNT1 O60563 1/20 0.35
▸ CCNB2 O95067 1/20 0.35
▸ CCNE2 O96020 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309256 1.00 HTR1A (0.39) HTR1AHTR7TSHRKMT2ARXFP1
SCHEMBL24309239 0.88 CCNT1 (0.40) TSHRKMT2APIK3CDPIK3CBMTOR
SCHEMBL29566741 0.87 HTR1A (0.43) HTR1AHTR7TSHRKMT2ARXFP1
SCHEMBL24309750 0.87 HTR1A (0.43) HTR1AHTR7TSHRKMT2ARXFP1
SCHEMBL24309726 0.84 HTR1A (0.43) HTR1AHTR7TSHRKMT2ARXFP1
SCHEMBL29566619 0.84 HTR1A (0.43) HTR1AHTR7TSHRKMT2ARXFP1
SCHEMBL24309266 0.83 NLRP3 (0.41) HTR1AHTR7TSHRKMT2AKDM4E
SCHEMBL24309875 0.81 HTR1A (0.39) HTR1AHTR7TSHRKMT2ARXFP1
SCHEMBL24309379 0.81 HTR1A (0.39) HTR1AHTR7TSHRKMT2ARXFP1
SCHEMBL24309824 0.79 BRAF (0.40) HTR1AHTR7TSHRKMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback